Allergen specific immunotherapy efficacy in children with pollen-food allergy syndrome and different IgE profiles to recombinant component-resolved allergens.

O. Ereshko (Moscow, Russian Federation)

Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Session: Evolution or revolution in the treatment of asthma and allergies
Session type: Thematic Poster
Number: 4036
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Ereshko (Moscow, Russian Federation). Allergen specific immunotherapy efficacy in children with pollen-food allergy syndrome and different IgE profiles to recombinant component-resolved allergens.. 4036

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
IgE specific for recombinant grass pollen allergens in allergic respiratory disease
Source: Eur Respir J 2005; 26: Suppl. 49, 380s
Year: 2005

Evaluation of specific IgE to recombinant pollen allergens in asthmatic patients with specific IgE to phleum pratense
Source: Eur Respir J 2001; 18: Suppl. 33, 434s
Year: 2001

Effect of allergen-specific immunotherapy on platelet secretory activity in patients with house-dust mite allergy
Source: Eur Respir J 2007; 30: Suppl. 51, 369s
Year: 2007

IgE antibodies in children with different types of allergy
Source: Eur Respir J 2001; 18: Suppl. 33, 435s
Year: 2001

Association between Th2 biomarker levels and efficacy of house dust mite sublingual allergy immunotherapy in adults with allergic asthma
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021


Evaluation and efficacy of allergen immunotherapy in asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 399s
Year: 2005

Specific allergen immunotherapy of asthma combined with allergic rhinitis
Source: Eur Respir J 2006; 28: Suppl. 50, 441s
Year: 2006

Sublingual allergen specific immunotherapy in children with respiratory allergies – long lasting efficacy
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017

Diagnostic utility of serum periostin for house dust mite sublingual immunotherapy response in allergic rhinitis
Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials
Year: 2021


Allergen immunotherapy: therapeutic vaccines for allergic diseases
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=409
Year: 2003

Safety of segmental allergen challenge in human allergic asthma
Source: Annual Congress 2007 - Novel aspects in airway inflammation in human asthma and rhinitis
Year: 2007



Clinical efficiency of sublingual and subcutaneous allergenspecific immunotherapy with household dust mite allergen in patients with persistent allergic rhinitis
Source: Eur Respir J 2006; 28: Suppl. 50, 438s
Year: 2006

How specific and sensitive are commercial specific IgE assays in the diagnosis of occupational asthma and allergy?
Source: Annual Congress 2009 - Occupational asthma in the clinic
Year: 2009


The influence of the allergen-specific immunotherapy (ASIT) against the backdrop of an immunomodulator in patients suffering from seasonal allergic rhinitis (SAR) on the level of cytokines, IgE and IgG.
Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others
Year: 2020


Allergen-specific IgE patterns in allergic diseases of respiratory system with atopic dermatitis.
Source: International Congress 2019 – Asthma and allergies worldwide
Year: 2019


Sensitisation patterns to food and inhalant allergens in childhood: a comparison of monosensitised and polysensitised children
Source: Annual Congress 2009 - Clinical advances in childhood asthma
Year: 2009


Impact of asthma-associated genetic polymorphisms on the efficacy of house dust mite sublingual allergy immunotherapy in adults with allergic asthma
Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science
Year: 2021



Sublingual immunotherapy is an established therapy for house dust mite sensitive allergic rhinitis and/or asthma
Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities
Year: 2007


Specific IgE sensitization and asthma in French farmers
Source: International Congress 2018 – Occupational and environmental lung diseases: asthma and the airways
Year: 2018